Daily Tribune (Philippines)

America spends $1.7-B against variants

In early February, US laboratori­es were only sequencing about 8,000 Covid-19 strains per week, thanks to an initial $200 million investment, the rate was now 29,000 samples a week

-

WASHINGTON, United States (AFP) — The administra­tion of United States (US) President Joe Biden on Friday announced it would spend $1.7 billion to improve its ability to sequence the coronaviru­s for genetic changes, as new and potentiall­y dangerous variants are poised to dominate the pandemic.

The funding comes from a $1.9 trillion Covid relief package passed last month and will help the US come up to speed on genomic surveillan­ce, an area in which it has lagged behind badly relative to other advanced countries.

“In early February, US laboratori­es were only sequencing about 8,000 Covid-19 strains per week,” a White House statement said, adding that thanks to an initial $200 million investment, the rate was now 29,000 samples a week.

The new funding includes $1 billion to expand federal and state

capacity to expand genomic surveillan­ce, $400 million to set up six cutting-edge research centers, and $300 million to build a national IT system for sharing and analyzing data.

An analysis by the Washington Post in December found that the US was 43rd in the world in its ability to sequence coronaviru­s cases.

This month, the variant first detected in the United Kingdom became the most dominant version of the coronaviru­s.

There are also fears about the rise of other variants, such as those first found in South Africa and in Brazil, which are better able to evade antibodies made in response to the original strain.

Vaccine makers are currently testing boosters tailored to variants and they could be made available towards the end of the year.

 ?? SILVIO AVILA/AGENCE FRANCE-PRESSE ?? THE new non-invasive technology that can reduce the need of intubation is used on a patient at the Covid-19 area of Centenario Hospital in Sao Leopoldo, Rio Grande do Sul state, southern Brazil. The impermeabl­e, transparen­t, sealed and inflatable bubble has respirator­y connection­s that allow pulmonary oxygenatio­n, reducing patient’s effort without the need for sedation.
SILVIO AVILA/AGENCE FRANCE-PRESSE THE new non-invasive technology that can reduce the need of intubation is used on a patient at the Covid-19 area of Centenario Hospital in Sao Leopoldo, Rio Grande do Sul state, southern Brazil. The impermeabl­e, transparen­t, sealed and inflatable bubble has respirator­y connection­s that allow pulmonary oxygenatio­n, reducing patient’s effort without the need for sedation.

Newspapers in English

Newspapers from Philippines